Richard S. Isaacson, MD is a Preventive Neurologist who conducts clinical and translational research at the Institute for Neurodegenerative Diseases, Florida. He founded and directed the first Alzheimer’s Prevention Clinic in the United States in 2013 at Weill Cornell Medicine/NewYork-Presbyterian.He previously served as Assistant Dean of Faculty Development and Associate Professor of Neurology at Weill Cornell Medicine & NewYork-Presbyterian. A graduate of the accelerated 6-year B.A./M.D. program at the University of Missouri – Kansas City School of Medicine, Dr. Isaacson specializes in AD risk reduction in patients with no cognitive complaints and a family history of the disease, and pre-clinical AD. 

His clinical research has shown that individualized clinical management of patients at risk for AD dementia may be an important strategy for optimizing cognitive function and reducing dementia risk. His recent work focuses on developing simple blood tests to make an early diagnosis, and track both disease progression and response to various risk-reducing therapy. He is a co-investigator on an NIH-funded clinical trial which began in early 2024 (YourBrainStudy.org) where people can learn about their risk factors, take memory tests and get personalized education all from the comfort of their cell phones.